Clinical trial

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

NCT06244056

Study summary

ClinicalTrials.gov

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2, PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

PROCEDURE · Unmapped registry intervention Stellate Ganglion Block Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-02-05

PhasePHASE2 / PHASE3

Conditions

Stellate Ganglion Blockunresolved

Interventions

Stellate Ganglion BlockPROCEDURE

Sponsors & collaborators

Mina sobhi said famlead sponsor

Mapped research locations

AsyutEgypt2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06244056 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.